Ace Therapeutics to launch custom in vivo ocular modeling services
This service will provide researchers with tailored animal models that closely mimic human ocular conditions.
(Image credit: AdobeStock/Mehemmed)
Ace Therapeutics is launching custom in vivo ocular modeling services, which are designed to accelerate advancements in ophthalmology research and enhance the discovery of therapeutic interventions. This service will provide researchers with tailored animal models that closely mimic human ocular conditions, enabling more reliable results in preclinical studies.1
Common animals used in in vivo ocular models include rodents, zebrafish, rabbits, mini pigs, canines, chickens, and non-human primates (NHPs).
Ace Therapeutics is a preclinical contract research provider offering comprehensive services. Its custom in vivo ocular modeling services fill a gap between ophthalmic preclinical study and clinical evaluation by providing customized ocular models that reflect the complexity of human eye diseases, including but not limited to glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and more.1
In the press release1 from the company, they credit the Chief Scientific Officer of Ace Therapeutics as saying, “Our mission at Ace Therapeutics has always been to empower scientists and researchers with the tools they need to uncover new treatment options for patients suffering from eye conditions. With our custom in vivo ocular modeling services, we are enabling a more precise understanding of disease mechanisms and therapeutic responses, ultimately leading to the development of more effective interventions.”
Ace Therapeutics is a full-service contract service provider engaged in ophthalmology preclinical research, Ace Therapeutics offers hundreds of validated ocular disease models with the help of gene knock-in, knock-out, and physicochemical stimulation.1
